|
2022: 3.8 billion euros) - exceeding the company's own expectations and demonstrating strong growth compared to its industry peers. Earnings grew substantially to yield adjusted EBITDA of 455.5 ...
Adnkronos
-
25-4-2024
|
|
|
...323.4 million, up 8.1% from $1,224.3 million in fiscal 2023 Profit of $140.1 million, compared to $137.3 million in fiscal 2023 Diluted earnings per share of $2.83, compared to $2.70 in fiscal 2023 ...
01Net
-
25-4-2024
|
|
|
First - quarter 2024 operating margin was 19.3%, compared with 18.5%. The adjusted operating margin in first - quarter 2024 was 21.2%, compared with 20.8%. The 40 - basis - point increase in adjusted ...
01Net
-
25-4-2024
|
|
|
But over half are facing challenges with the skills gap - compared to a third in 2019 - and a separate 56% raised concerns over recruitment. Chris Anstead, a Director in the Global Programme Advisory ...
01Net
-
25-4-2024
|
|
|
|
Regarding the construction activity (including M Concessions), the Earnings before Taxes, Interests and Depreciation (EBITDA) amounted to 3 million in Q1 2024, compared to 5 million in Q1 2023, due ...
Adnkronos
-
25-4-2024
|
|
|
Funded backlog as of March 31, 2024 was $3.2 billion compared with $3.4 billion a year ago, a decrease of 5.9 percent. The change in funded backlog was driven by normal variation in timing of funding ...
01Net
-
25-4-2024
|
|
|
GAAP diluted loss per share was $0.88, compared to diluted loss per share of $0.47 in the prior quarter, and diluted earnings per share of $0.12 in the year - ago quarter. Non - GAAP basis: Non - ...
01Net
-
25-4-2024
|
|
|
This is not something that can be compared with another. So in the face of this reality, homosexual acts have this characteristic, which cannot even remotely reflect this immense beauty. That is what ...
Il Cattolico
-
25-4-2024
|
|
|
|
In 2023, the total import - export volume of the western region increased 37 percent compared to 2019. As the western region is the birthplace of China's great rivers such as the Yangtze River, ...
Adnkronos
-
24-4-2024
|
|
|
|
... if approved, would represent significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications. 2 If ...
Adnkronos
-
24-4-2024
|
|
|